Scotiabank analyst Allan Verkhovski raised the firm’s price target on Monday.com (MNDY) to $400 from $300 and keeps an ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform ...